# CTO Directive Buy-In Review - 2026-06-13

Owner: CTO
Status: Accepted with evidence-preserving revisions
Canonical authority: `docs/CANONICAL_REFERENCE.md`, `docs/BUILD_PROTOCOL.md`, `docs/IMPLEMENTATION_PLAN.md`

## Verdict

I accept the W04/CEO comprehensive directive as the correct operating strategy: one priority at a time, no fabricated delivery claims, no VERIFIED movement without evidence fields and W04/CEO clearance, and repo-based bench coordination through `docs/cto/`.

Do not commit the pasted directive verbatim over `docs/cto/current-directive.md`. The current repo directive already integrates the same strategy with evidence corrections required by the SSOT.

## Required Evidence Corrections

The pasted draft says `VERIFIED matrixArtifact entries: 1 (saige-v2 Migration)`. The active artifact does not support that. Current active matrixArtifact state is:

- `VERIFIED`: 0
- `CURRENT`: 2
- total entries: 39

Path 1 Migration has CT2-confirmed deployed URL evidence at `https://saige-v2.vercel.app`, but the matrixArtifact row has not been promoted to `VERIFIED`. Treat that as a promotion candidate only.

The pasted draft says Milestone 1 Axis Wiring is in progress with preflight pending. Current repo evidence supersedes that:

- Runtime axis wiring and label clarity are merged.
- Production runtime commit `65f46a0c96930a207e7cd0c0160cf51317c89822` was promoted.
- CT2 rerun returned PASS for sidebar labels, independent axis selection, route switching, request payload propagation, and run-log axis envelope.
- No VERIFIED movement has been applied.

Codex TIM Build must not be included in the first VERIFIED batch until a live Step 3 Build run proves Codex was selected and used. Existing code, tests, health, and ranking readiness are not enough for VERIFIED.

## Implementation Revisions

1. `docs/cto/current-directive.md` remains the active directive because it already contains the needed corrections.
2. `docs/cto/verified-promotion-packet-milestone1-20260613.md` is the next governance packet; W04/CEO must approve exact matrix row mapping before any edit.
3. Production SHA checks must distinguish runtime commits from docs-only evidence commits. Production should match the latest runtime commit, not necessarily the latest `main` commit when newer commits are docs-only.
4. Clerk auth diagnostic may proceed as a non-code audit while the VERIFIED packet waits on clearance. Runtime implementation work should remain one active milestone at a time.
5. Path 2 and Path 3 proof runs should start only after the current promotion decision is recorded, unless W04 explicitly pauses promotion and clears the next runtime proof.

## Next CTO Actions

1. Wait for W04/CEO matrix mapping decision or record that the first VERIFIED batch is deferred.
2. If cleared, dispatch a narrow matrix cleanup branch with CD and CR review before merge.
3. Run Clerk credential diagnostic from Doppler and production health without changing code.
4. Resume URL-producing proof work: Path 2 Production on app-layer-owned codebase, then Path 3 Fresh Build.

## No Canonical Amendment

This directive does not require editing `docs/CANONICAL_REFERENCE.md`, `docs/BUILD_PROTOCOL.md`, or `docs/IMPLEMENTATION_PLAN.md`. It is an executive coordination layer only. Canonical authority remains unchanged.
